These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 20693194)

  • 1. The interferon-alpha signature of systemic lupus erythematosus.
    Obermoser G; Pascual V
    Lupus; 2010 Aug; 19(9):1012-9. PubMed ID: 20693194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
    Wang H; Li T; Chen S; Gu Y; Ye S
    Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Type-I IFN subtype autoantibodies and activity in SLE serum and urine.
    Harris BD; Kuruganti S; Deshpande A; Goepfert PA; Chatham WW; Walter MR
    Lupus; 2020 Aug; 29(9):1095-1105. PubMed ID: 32611267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b.
    Khan WA; Qureshi JA
    APMIS; 2015 Dec; 123(12):1016-24. PubMed ID: 26547367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I interferon in systemic lupus erythematosus.
    Crow MK
    Curr Top Microbiol Immunol; 2007; 316():359-86. PubMed ID: 17969456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Plasmacytoid Dendritic Cells-Type I Interferon Axis Is Critically Implicated in the Pathogenesis of Systemic Lupus Erythematosus.
    Kim JM; Park SH; Kim HY; Kwok SK
    Int J Mol Sci; 2015 Jun; 16(6):14158-70. PubMed ID: 26110387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic identification of novel SLE related autoantibodies responsible for type I IFN production in human plasmacytoid dendritic cells.
    Kassim SH; Jordan J; Schreiter J; Adhikarakunnathu S; Baribaud F; San Mateo L
    Cell Immunol; 2013; 284(1-2):119-28. PubMed ID: 23973875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification.
    Munroe ME; Lu R; Zhao YD; Fife DA; Robertson JM; Guthridge JM; Niewold TB; Tsokos GC; Keith MP; Harley JB; James JA
    Ann Rheum Dis; 2016 Nov; 75(11):2014-2021. PubMed ID: 27088255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into the immunopathogenesis of systemic lupus erythematosus.
    Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
    Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Type I interferon in the pathogenesis of systemic lupus erythematosus.
    Postal M; Vivaldo JF; Fernandez-Ruiz R; Paredes JL; Appenzeller S; Niewold TB
    Curr Opin Immunol; 2020 Dec; 67():87-94. PubMed ID: 33246136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon-α abrogates the suppressive effect of apoptotic cells on dendritic cells in an in vitro model of systemic lupus erythematosus pathogenesis.
    Abeler-Dörner L; Rieger CC; Berger B; Weyd H; Gräf D; Pfrang S; Tarner IH; Schwarting A; Lorenz HM; Müller-Ladner U; Krammer PH; Kuhn A
    J Rheumatol; 2013 Oct; 40(10):1683-96. PubMed ID: 24037549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The many faces of type I interferon in systemic lupus erythematosus.
    Mauri C; Menon M
    J Clin Invest; 2015 Jul; 125(7):2562-4. PubMed ID: 26098208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type I interferon signature in systemic lupus erythematosus.
    Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
    Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
    Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
    Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unraveling the Link between Interferon-α and Systemic Lupus Erythematosus: From the Molecular Mechanisms to Target Therapies.
    Infante B; Mercuri S; Dello Strologo A; Franzin R; Catalano V; Troise D; Cataldo E; Pontrelli P; Alfieri C; Binda V; Frontini G; Netti GS; Ranieri E; Gesualdo L; Castellano G; Stallone G
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of incomplete clearance of apoptotic cells in the etiology and pathogenesis of SLE].
    Muñoz LE; Lauber K; Schiller M; Manfredi AA; Schett G; Voll RE; Herrmann M
    Z Rheumatol; 2010 Mar; 69(2):152, 154-6. PubMed ID: 20107814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum antibodies to human leucocyte antigen (HLA)-E, HLA-F and HLA-G in patients with systemic lupus erythematosus (SLE) during disease flares: Clinical relevance of HLA-F autoantibodies.
    Jucaud V; Ravindranath MH; Terasaki PI; Morales-Buenrostro LE; Hiepe F; Rose T; Biesen R
    Clin Exp Immunol; 2016 Mar; 183(3):326-40. PubMed ID: 26440212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-alpha: a therapeutic target in systemic lupus erythematosus.
    Crow MK
    Rheum Dis Clin North Am; 2010 Feb; 36(1):173-86, x. PubMed ID: 20202598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon-alpha in systemic lupus erythematosus.
    Crow MK; Kirou KA
    Curr Opin Rheumatol; 2004 Sep; 16(5):541-7. PubMed ID: 15314491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray analysis of interferon-regulated genes in SLE.
    Crow MK; Kirou KA; Wohlgemuth J
    Autoimmunity; 2003 Dec; 36(8):481-90. PubMed ID: 14984025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.